Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

Kidney International

Volumn 73, Issue 11, 2008, Pages 1282-1288

  Leung, N ^a   Gertz, M A ^a   Zeldenrust, S R ^a   Rajkumar, S V ^a   Dispenzieri, A ^a   Fervenza, F C ^a   Kumar, S ^a   Lacy, M Q ^a   Lust, J A ^a   Greipp, P R ^a   Witzig, T E ^a   Hayman, S R ^a   Russell, S J ^a   Kyle, R A ^a   Winters, J L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cast nephropathy; Myeloma kidney; Plasma exchange

Indexed keywords

CREATININE; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY;

ADULT; AGED; CANCER PATIENT; CAST NEPHROPATHY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; MALE; MULTIPLE MYELOMA; NOTE; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

EID: 43749109850     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.108     Document Type: Article

References (27)

1. R. Alexanian B. Barlogie D. Dixon Renal failure in multiple myeloma. Pathogenesis and prognostic implications Arch Intern Med 150 1990 1693 1695
2. J. Blade P. Fernandez-Llama F. Bosch Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution Arch Intern Med 158 1998 1889 1893
3. H.C. Rayner A.P. Haynes J.R. Thompson Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988 Quart J Med 79 1991 517 525
4. V. Sakhuja V. Jha S. Varma Renal involvement in multiple myeloma: a 10-year study Renal Failure 22 2000 465 477
5. L.M. Knudsen M. Hjorth E. Hippe Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group Eur J Haematol 65 2000 175 181
6. S. Rota B. Mougenot B. Baudouin Multiple myeloma and severe renal failure: a clinicopathologic study of outcome and prognosis in 34 patients Medicine 66 1987 126 137
7. G.A. Herrera Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory Ann Diagn Pathol 4 2000 174 200
8. B. Ivanyi Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma Arch Pathol Lab Med 114 1990 986 987
9. G.A. Herrera L. Joseph X. Gu Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia [see comment] Arch Pathol Lab Med 128 2004 875 879
10. R. Confalonieri G. Barbiano di Belgiojoso G. Banfi Light chain nephropathy: histological and clinical aspects in 15 cases Nephrol Dial Transplant 3 1988 150 156
11. E.H. Strom G.B. Fogazzi G. Banfi Light chain deposition disease of the kidney. Morphological aspects in 24 patients Virchows Arch 425 1994 271 280
12. A. Fogo N. Qureshi R.G. Horn Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy [see comment] [erratum appears in Am J Kidney Dis 1993 Nov;22(5):757] Am J Kidney Dis 22 1993 367 377
13. S.H. Nasr G.S. Markowitz M.B. Stokes Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis Kidney Int 65 2004 85 96
14. P. Paueksakon M.P. Revelo R.G. Horn Monoclonal gammopathy: significance and possible causality in renal disease Am J Kidney Dis 42 2003 87 95
15. R.A. Sirsat R.B. Deshpande Multiple myeloma presenting as proliferative (crescentic) glomerulonephritis J Postgrad Med 40 1994 92 93
16. S.M. Soares D.J. Lager N. Leung A proliferative glomerulonephritis secondary to a monoclonal IgA Am J Kidney Dis 47 2006 342 349
17. N. Leung S.V. Rajkumar Renal manifestations of plasma cell disorders Am J Kidney Dis 50 2007 155 165
18. J. Lin G.S. Markowitz A.M. Valeri Renal monoclonal immunoglobulin deposition disease: the disease spectrum J Am Soc Nephrol 12 2001 1482 1492
19. P. Zucchelli S. Pasquali L. Cagnoli Controlled plasma exchange trial in acute renal failure due to multiple myeloma Kidney Int 33 1988 1175 1180
20. W.J. Johnson R.A. Kyle A.A. Pineda Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy Arch Intern Med 150 1990 863 869
21. W.F. Clark A.K. Stewart G.A. Rock Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial [see comment] [summary for patients in Ann Intern Med . 2005 Dec 6;143(11):I20; PMID: 16330784] Ann Intern Med 143 2005 777 784
22. T.G. Feest P.S. Burge S.L. Cohen Successful treatment of myeloma kidney by diuresis and plasmaphoresis BMJ 1 1976 503 504
23. B.G. Durie J.L. Harousseau J.S. Miguel International uniform response criteria for multiple myeloma Leukemia 20 2006 1467 1473
24. Z.M. Szczepiokkowski N. Bandarenko H.C. Kim Guidelines on the use of therapeutic apheresis in clinical practice—Evidence-based approach from the Clinical Applications Committee of the American Society for Apheresis J Clin Apher 22 2007 106 175
25. N. Leung Plasma exchange in multiple myeloma [comment] Ann Inter Med 144 2006 455 author reply 455
26. C.A. Hutchison P. Cockwell S. Reid Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies J Am Soc Nephrol 18 2007 886 895
27. A.S. Levey J. Coresh T. Greene Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values Clin Chem 53 2007 766 772